Simple Summary FAPI represents a novel class of radiotracers demonstrating promising
results in terms of a high uptake in concordance with low background noise in several …

Fibroblast activation protein (FAP), a type II transmembrane serine protease, is highly
expressed in more than 90% of epithelial tumors and is closely associated with various …

Purpose Fibroblast activation protein (FAP) is a cell membrane–bound serine peptidase,
overexpressed in cancer-associated fibroblasts and activated fibroblasts at wound …

Despite revolutionizing the field of oncological imaging, Positron Emission Tomography
(PET) with [18F] Fluorodeoxyglucose (FDG) as its workhorse is limited by a lack of specificity …

Fibroblast activation protein (FAP), a membrane-anchored peptidase, is highly expressed in
cancer-associated fibroblasts in more than 90% of epithelial tumors and contributes to …

Fibroblast-activation protein (FAP) is a serine protease classified in the dipeptidyl peptidase
4 (DPP4) family. FAP is predominantly expressed in activated fibroblasts such as the cancer …

Gallium 68 (68Ga)–labeled fibroblast activation protein (FAP) inhibitor (FAPI) PET is based
on the molecular targeting of the FAP, which is known to be highly expressed in the major …

Fibroblast activation protein inhibitor (FAPI) is a promising tracer in oncologic positron
emission tomography/computed tomography (PET/CT). Numerous studies have …

Fibroblast activation protein (FAP) is a type II membrane-bound glycoprotein which is
overexpressed in cancer-associated fibroblasts and activated fibroblasts at wound …

Purpose A high expression of fibroblast activation protein (FAP) was observed in multiple
sarcomas, indicating an enormous potential for PET/CT using 68 Ga-radiolabeled inhibitors …